Treatment failure and recurrence of Clostridium difficile infection following treatment with vancomycin or metronidazole: a systematic review of the evidence
- 7 March 2012
- journal article
- research article
- Published by Elsevier BV in International Journal of Antimicrobial Agents
- Vol. 40 (1), 1-8
- https://doi.org/10.1016/j.ijantimicag.2012.01.004
Abstract
No abstract availableKeywords
This publication has 53 references indexed in Scilit:
- The Impact of angiotensin-converting enzyme inhibitors and angiotensin-receptor blockers in patients with Clostridium difficile infectionMedical Hypotheses, 2011
- Clostridium difficile Infection and Treatment in the Pediatric Inflammatory Bowel Disease PopulationJournal of Pediatric Gastroenterology and Nutrition, 2011
- Diabetes mellitus as a risk factor for recurrence of Clostridium difficile infection in the acute care hospital settingAmerican Journal of Infection Control, 2011
- Risk Factors for Treatment Failure and Recurrence after Metronidazole Treatment for Clostridium difficile-associated DiarrheaGut and Liver, 2010
- Postoperative Clostridium difficile-associated diarrheaSurgery, 2010
- Clostridium difficile infection in Polish pediatric outpatients with inflammatory bowel diseaseEuropean Journal of Clinical Microbiology & Infectious Diseases, 2010
- Rifaximin therapy for metronidazole-unresponsive Clostridium difficile infection: a prospective pilot trialTherapeutic Advances in Gastroenterology, 2010
- A Prospective Study of Risk Factors and Historical Trends in Metronidazole Failure for Clostridium difficile InfectionClinical Gastroenterology and Hepatology, 2008
- A Comparison of Vancomycin and Metronidazole for the Treatment of Clostridium difficile-Associated Diarrhea, Stratified by Disease SeverityClinical Infectious Diseases, 2007
- Hospital-acquired Clostridium difficile-associateddisease in the intensive care unit setting: epidemiology, clinical course and outcomeBMC Infectious Diseases, 2007